The global 3D cell culture market is poised to reach $ 2,750 million by 2020, at an estimated CAGR of 30.6% from 2015 to 2020. This high growth rate of the market is attributed to the factors such as increasing investments and funding by government and non-government bodies in the global 3D cell culture market for aiding the development of innovative products and tools, increased 3D cell culture based cancer research activities, and rising use of 3D cell culture in drug discovery & toxicology testing since the effect of drug doses can be studied more effectively in 3D cell culture as compared to conventional 2D cell culture. In addition, the use of 3D cell culture models as a tool against animal lobbying, and the rapid increase in the need for liver and other organ transplantation is also further expected to propel the growth in the coming years.
Early buyers will receive 10% discount on the report.
Cosmetics market and regenerative medicine offers huge potential to the growth of this market in the coming five years, hence these are looked upon as promising opportunity areas for 3D cell culture market in future. However, conservative outlook of the researchers to adapt to 3D cell culture market at a rapid pace, and lack of consistency in products between wells and batches of cell culture are factors restraining the growth of the market.
The research report on the global 3D cell culture market provides comprehensive analysis of the global market with a regional level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major technologies and product segments such as scaffold-free platforms, scaffold- based platforms, bioreactors, and microchips. The scaffold-free platforms market is further sub-segmented into low attachment surfaces, and hanging drop method. Similarly, the scaffold-based platforms market is further sub-segmented into hydrogels, porous scaffolds, and fibrous scaffolds. On the basis of application, the 3D cell culture market is segmented into five segments namely, clinical applications, drug discovery & toxicology, research (academic & basic laboratories), stem cell research, and tissue engineering. Market size estimates and forecasts for the period 2013 to 2020 has been provided for each segment and its sub-segment, in terms of USD million, calculating growth rates from 2015 to 2020, considering 2014 as the base year for calculations. The global 3D cell culture market is segmented by geography as North America, Europe, Asia, and Rest of the World (RoW). These regions analyzed with a detailed qualitative and quantitative insights.
In terms of technology, scaffold-based technology which includes hydrogels, porous scaffolds, and fibrous scaffolds is set to grow rapidly in the coming five years. The largest application area for 3D cell culture is clinical applications such as personalized medicines and cancer research. 3D cell culture model plays a vital role in cancer research. A number of cancer model systems are available to investigate disease mechanisms and to screen therapies.
North America dominates the 3D cell culture market in the year 2015, followed by Europe and Asia. Asia is slated to witness highest growth rate in the coming five years with China, Japan, Taiwan, India, Malaysia, and Singapore witnessing significant growth in the 3D cell culture market, as a result of their economic development, rising awareness regarding cancer in these countries, huge production of drugs in this region, and the growing focus of 3D cell culture players in these markets.
As research demands have become increasingly complex, there is a rising need for better 3D cell culture techniques. Citing this, various companies are introducing 3D cell culture products using their own technologies. This competitive approach has led to rapid development of 3D cell culture products in the market. The 3D cell culture market is fragmented showing the presence of few large players and many small players. The major players in the global 3D cell culture market are BD Biosciences, Thermo Fisher Scientific, Corning Life Sciences, Sigma-Aldrich, and Lonza Group, 3D Biomatrix, Inc., 3D Biotek LLC, Reinnervate Ltd., Insphero AG, and Nanofiber Solutions, LLC among others.
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia¬-Pacific, and Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123